Skip to main content
Carasent logo

Carasent — Investor Relations & Filings

Ticker · CARA ISIN · NO0010123060 LEI · 5967007LIEEXZXI9ZS60 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2023-11-30 Board/Management Inform…
Country NO Norway
Listing OL CARA

About Carasent

https://carasent.com/

Carasent is a health technology group focused on enhancing efficiency and quality in the healthcare sector. The company develops and provides mission-critical, cloud-based software solutions, with a primary focus on Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems, often delivered as Software as a Service (SaaS). With over 30 years of experience, Carasent also offers a suite of integrated ecosystem services designed to automate and streamline clinical and administrative workflows. By integrating its core platforms with proprietary and third-party applications, the company creates seamless processes that reduce administrative burdens for customers in the healthcare, rehabilitation, and occupational health sectors.

Recent filings

Filing Released Lang Actions
Carasent ASA - Resignation of board member
Board/Management Information Classification · 99% confidence The document explicitly announces the 'Resignation of board member Staffan Hanstorp' from the board of directors of Carasent ASA. This directly relates to changes in the company's board of directors or senior management. According to the definitions, this corresponds to the Board/Management Information category (MANG). The document is short and contains the announcement itself, not a link to a larger report.
2023-11-30 English
Carasent ASA - Financial calendar
Report Publication Announcement Classification · 98% confidence The document is titled 'Financial calendar for Carasent ASA' and lists future dates for various corporate events, including 'Quarterly Report', 'Half-yearly Report', 'Annual Report', and 'Annual General Meeting'. It is not the report itself, but an announcement detailing the schedule for future report publications. Given the options, the most appropriate classification for an announcement about the timing/release of reports is 'Report Publication Announcement' (RPA). The document length is very short (488 chars), supporting the idea that it is an announcement rather than the full report.
2023-11-24 English
Carasent ASA - Financial calendar
Report Publication Announcement Classification · 98% confidence The document is titled 'Carasent ASA - Financial calendar' and lists scheduled dates for future financial events such as Quarterly Reports, Half-yearly Reports, Annual Reports, and the Annual General Meeting (AGM). It is not the report itself, but rather an announcement detailing the schedule of future reports and meetings. Since there is no specific category for a 'Financial Calendar' and the document is very short (539 chars), it functions as a general regulatory announcement regarding future corporate actions and disclosures. This fits best under the general 'Regulatory Filings' (RNS) category, as it is an informational update about the company's schedule, rather than a specific report type like ER, IR, or 10-K.
2023-11-24 English
Carasent group signs contract to supply Metodika EPM to Volvat Medisinske Senter AS
Regulatory Filings Classification · 100% confidence The document announces a significant business event: Carasent group signing a contract to supply its Metodika EPM system to Volvat Medisinske Senter AS. This involves a new contract, estimated annual revenue (7-9 MNOK), and strategic implications for the company. This type of announcement, detailing a major commercial agreement or partnership, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or corporate governance filings (like DEF 14A, DVA). It is a material business update that is typically released via regulatory channels but is not a standard SEC form. Given the options, the most appropriate classification for a significant, non-standard business development announcement that is material to investors, but doesn't fit other specific categories, is the general 'Regulatory Filings' fallback category (RNS), as these announcements are often disseminated via a Regulatory News Service or similar mechanism to ensure broad market awareness.
2023-11-21 English
Carasent group signs contract to supply Metodika EPM to Volvat Medisinske Senter AS
Regulatory Filings Classification · 100% confidence The document announces a significant business event: Carasent group signing a contract to supply its Metodika EPM system to Volvat Medisinske Senter AS. This involves a new agreement, estimated annual revenue (7-9 MNOK), and implementation timelines. This type of announcement, detailing a major commercial contract or partnership, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, DIV, etc.). It is a general corporate announcement regarding business operations and potential future revenue streams. Since it is not a standard regulatory filing like a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ), and it's not about M&A (TAR), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for corporate announcements.
2023-11-21 English
Carasent ASA - primary insider trading
Director's Dealing Classification · 99% confidence The document explicitly states 'Carasent ASA - primary insider trading' and details a share acquisition by the CFO, Svein Martin Bjørnstad. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). The appropriate code is DIRS.
2023-11-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.